ARCHIVES

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

This article is from The Cancer Letter archive.

Vol. 31 No. 30 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It

October 22, 1982

Funding Opportunities

December 13, 2002

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

In Brief: Takeo Kakanaga Dies; President’s Cancer Panel to Meet Nov. 7; Young To Give Schwartz Lecture

October 7, 1988

NIH Probing: Double Dipping” Allegation

September 4, 1981